Update date
31 Dec 2020
Shareable Research Card
This metric view shows TRIB - TRINITY BIOTECH PLC interest expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported interest expense: $6,751,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2020
Page type
Metric history
Latest period
2020
SEC-backed company facts were refreshed from filings filed on 16 May 2025.
Benchmark Context
TRINITY BIOTECH PLC sits in the bottom quarter of the current interest expense sample.
Compared with
Compared with 120 companies reporting interest expense in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.1x the current sample midpoint. Interest Expense is up about 2.6% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: 2020. Period end: 31 Dec 2020. Units: USD. Frequency: annual.
Interest Expense is an SEC-reported metric from company XBRL facts.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare latest available Interest Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
TRINITY BIOTECH PLC appears at rank #94 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | HSBC HOLDINGS PLC (hsbc) | $63,078,000,000 | Year - 31 Dec 2025 | Open HSBC HOLDINGS PLC Interest Expense |
| 2 | KB Financial Group Inc. (kb) | $11,952,871,000 | Year - 31 Dec 2024 | Open KB Financial Group Inc. Interest Expense |
| 3 | BROOKFIELD Corp /ON/ (bn) | $10,702,000,000 | Year - 31 Dec 2022 | Open BROOKFIELD Corp /ON/ Interest Expense |
| 4 | WOORI FINANCIAL GROUP INC. (wf) | $8,881,600,000 | Year - 31 Dec 2024 | Open WOORI FINANCIAL GROUP INC. Interest Expense |
| 5 | Shell plc (shel) | $4,671,000,000 | Year - 31 Dec 2025 | Open Shell plc Interest Expense |
| 6 | Brookfield Infrastructure Partners L.P. (bip) | $3,868,000,000 | Year - 31 Dec 2025 | Open Brookfield Infrastructure Partners L.P. Interest Expense |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2020 | $6,751,000 | +$169,000 | +2.6% | 01 Jan 2020 | 31 Dec 2020 | 20-F | 30 Apr 2021 | 2020 | FY |
| 2019 | $6,582,000 | +$1,502,000 | +30% | 01 Jan 2019 | 31 Dec 2019 | 20-F | 30 Apr 2021 | 2020 | FY |
| 2018 | $5,080,000 | -$325,000 | -6% | 01 Jan 2018 | 31 Dec 2018 | 20-F | 30 Apr 2021 | 2020 | FY |
| 2017 | $5,405,000 | -$34,000 | -0.62% | 01 Jan 2017 | 31 Dec 2017 | 20-F | 15 Jun 2020 | 2019 | FY |
| 2016 | $5,439,000 | +$1,385,000 | +34% | 01 Jan 2016 | 31 Dec 2016 | 20-F | 14 May 2019 | 2018 | FY |
| 2015 | $4,054,000 | 01 Jan 2015 | 31 Dec 2015 | 20-F | 20 Apr 2018 | 2017 | FY |